Skip to content

Comparing the results of treatment with three methods of electrical stimulation, magnetic stimulation and combination therapy (with electrical and magnetic stimulation), in women with urge urinary incontinence

Comparing the results of treatment with three methods of electrical stimulation, magnetic stimulation and combination therapy (with electrical and magnetic stimulation), in women with urge urinary incontinence: a clinical trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20090427001853N19
Enrollment
126
Registered
2025-03-26
Start date
2025-04-09
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

urinary incontinence. Other specified urinary incontinence

Interventions

Intervention 1: Intervention group 1: A12-session treatment through functional magnetic stimulation by magnetic chair stimulation from NOVA medtech, made in Turkey, for 30 min per session, once per we
for patients with urge incontinence, in two phases with low frequency and each phase for 10 minutes with a power of 30-100 Hz. For patients with mixed incontinence, in two phases: the first phase with

Sponsors

Urology Research Center, Guilan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: aged 18-75 years normal complete urine test

Exclusion criteria

Exclusion criteria: Overflow urinary incontinence Complete urinary incontinence pregnant women diabetics patients with pacemakers or any metal devices inside the body history of receiving electromagnetic treatments residual urine more than 100 cc after urination neurological diseases spinal cord injury severe weakness of the urethral sphincter history of any pelvic surgery pelvic organ prolapses

Design outcomes

Secondary

MeasureTime frame
Concomitant stress urinary incontinence. Timepoint: Before the start of the study, after the end of treatment and 6 months after the end of treatment. Method of measurement: International Consultation on Incontinence Questionnaire Short Form (ICIQ-SF).

Primary

MeasureTime frame
Severity of urge urinary incontinence. Timepoint: Before the start of the study, after the end of treatment and 6 months after the end of treatment. Method of measurement: International Consultation on Incontinence Questionnaire Short Form (ICIQ-SF).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAli Hamidi Madani

Urology Research Center, Guilan University of Medical Sciences

a.hamidimadani@gmail.com+98 13 3352 5259

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026